Drug Development Research
Copyright © 2014 Wiley Periodicals Inc.
Edited By: Michael Williams
Impact Factor: 0.869
ISI Journal Citation Reports © Ranking: 2012: 54/59 (Chemistry Medicinal); 214/261 (Pharmacology & Pharmacy)
Online ISSN: 1098-2299
Recently Published Issues
Having trouble accessing the journal?
All readers can access journal abstracts and a table of contents for each issue, but if your institution subscribes you get even more! Pages and pages of groundbreaking new research is online and available for you to view, cite and read- from cover- to- cover. Get in the know today and recommend that your library subscribe.
Special Issues and Articles
Denong Wang, Laila Dafik1, Rosalie Nolley, Wei Huang, Russell D. Wolfinger, Lai-Xi Wang, Donna M. Peehl
Prostate cancer (PCa) is the most common noncutaneous malignancy in men. Based on autopsy studies, a significant number of American men in their 30s already have cancer in their prostates; this frequency rises to about 80% for men in their 70s. Despite such a high incidence of PCa, only 8% of men in the United States in their lifetime present with clinically significant disease that affects their quality of life [Stamey et al., 1993], and only 3% of all men in the United States die of PCa [Ries, 1994]. No other human cancer possesses such an enormous disparity between the very high incidence of malignancy microscopically and the relatively low death rate. Read on